Phase 2 Lung Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 or older, of any gender
- People diagnosed with stage IV non-small cell lung cancer (a type of lung cancer) whose disease has not responded to at least one previous standard treatment — with specific prior treatment requirements depending on whether certain gene mutations are present in the cancer (confirm with trial site)
- People whose cancer has at least one measurable tumour, as assessed using standard imaging guidelines
- People whose blood test results meet specific thresholds for red blood cells, white blood cells, platelets, kidney function, liver function, and protein levels (confirm with trial site for exact values)
- People with a general health and activity level rated 0–2 on a standard scale used by doctors (meaning able to carry out at least some self-care)
- People with an expected survival of at least 3 months
- Women who could become pregnant must have a negative pregnancy blood test before joining, and must use reliable contraception from signing the consent form until 3 months after the last dose
- People who understand and are willing to sign the informed consent form
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously been treated with the chemotherapy drug docetaxel
- People diagnosed with another cancer (other than non-small cell lung cancer) within the past 5 years — though certain skin cancers that were fully treated or removed may be exceptions (confirm with trial site)
- People with uncontrolled heart disease affecting blood flow, or significant heart failure classified at a severe level
- People who have had a stroke or major heart or blood vessel event in the 6 months before joining
- People with a specific abnormality in heart rhythm (measured on an ECG) above certain thresholds, including a different threshold for those with a ventricular pacemaker (confirm with trial site)
- People with HIV or known syphilis infection
- People who have previously had a bone marrow or stem cell transplant
- People who have a known allergy to the study drug or any of its ingredients
- People the trial doctors consider unsuitable for the study for other reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Incidence of grade ≥ 3 neutropenia during chemotherapy treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.